Coverage

The First Circuit on Monday revived an antitrust suit alleging Momenta Inc. and Sandoz Inc. misled regulators about their patent on the industry test for an anticoagulant so they could squeeze rival Amphastar Pharmaceuticals Inc. out of the market with infringement claims, finding the district court erroneously applied the Noerr-Pennington doctrine.